Correlation Between Stryker and Nu Med

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stryker and Nu Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Nu Med into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stryker and Nu Med Plus, you can compare the effects of market volatilities on Stryker and Nu Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Nu Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Nu Med.

Diversification Opportunities for Stryker and Nu Med

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Stryker and NUMD is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Nu Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of Stryker i.e., Stryker and Nu Med go up and down completely randomly.

Pair Corralation between Stryker and Nu Med

Considering the 90-day investment horizon Stryker is expected to under-perform the Nu Med. But the stock apears to be less risky and, when comparing its historical volatility, Stryker is 12.51 times less risky than Nu Med. The stock trades about -0.33 of its potential returns per unit of risk. The Nu Med Plus is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  1.90  in Nu Med Plus on October 5, 2024 and sell it today you would lose (0.36) from holding Nu Med Plus or give up 18.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Stryker  vs.  Nu Med Plus

 Performance 
       Timeline  
Stryker 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Stryker is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Nu Med Plus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nu Med Plus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Stryker and Nu Med Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stryker and Nu Med

The main advantage of trading using opposite Stryker and Nu Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Nu Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will offset losses from the drop in Nu Med's long position.
The idea behind Stryker and Nu Med Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios